RSG
53
3
IP
54
4
EQT
56
2
PRU
40
-4
MCK
56
3
COST
54
4
OI
30
-4
VMC
33
3
ITW
33
2
PHM
43
6
SLB
37
-4
UNM
63
-2
CLX
68
2
KMI
79
2
GLW
50
-2
MSI
47
4
TXN
38
3
ADP
66
4
BAC
56
2
CSCO
67
3
RSG
53
3
IP
54
4
EQT
56
2
PRU
40
-4
MCK
56
3
COST
54
4
OI
30
-4
VMC
33
3
ITW
33
2
PHM
43
6
SLB
37
-4
UNM
63
-2
CLX
68
2
KMI
79
2
GLW
50
-2
MSI
47
4
TXN
38
3
ADP
66
4
BAC
56
2
CSCO
67
3
Financhill
Back

Simulations Plus Vs. Novo Nordisk AS Industry Stock Comparison

Sell
39

SLP
Simulations Plus

Last Price:
$28.05
Seasonality Move:
23.12%
Sell
25

NVO
Novo Nordisk AS

Last Price:
$86.13
Seasonality Move:
6.68%
Sell
39
Simulations Plus (SLP) is a Sell

Is Simulations Plus a Buy, Sell or Hold?

  • The current Simulations Plus [SLP] share price is $28.21. The Score for SLP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • SLP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.64. The Score for NVO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SLP Stock Price Chart

What is Simulations Plus's stock price today?

  • The Simulations Plus share price today is $28.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLP is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

SLP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 43.4 Sell
Chaikin Money Flow: 1528537 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.31 - 30.81) Sell
Bollinger Bands (100): (28.89 - 34.07) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.06 Sell
Relative Strength Index (14 RSI): 31.71 Sell
Chaikin Money Flow: 6521757 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.72 - 109.1) Sell
Bollinger Bands (100): (99.51 - 129.55) Sell

SLP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.6 Sell
20-day SMA: 29.31 Sell
50-day SMA: 29.81 Sell
200-day SMA: 38.02 Sell
8-day EMA: 28.83 Sell
20-day EMA: 29.18 Sell
50-day EMA: 30.12 Sell
200-day EMA: 35.42 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 86.04 Sell
20-day SMA: 94.95 Sell
50-day SMA: 102.54 Sell
200-day SMA: 123.74 Sell
8-day EMA: 86.81 Sell
20-day EMA: 92.64 Sell
50-day EMA: 101.62 Sell
200-day EMA: 114.8 Sell

Simulations Plus Earnings Growth & SLP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.11 per share, an increase this year of $0.54 per share, and an increase next year of $0.18 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.54 per share.

Simulations Plus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):